Navigation Links
Combo therapies tested to overcome drug resistance in melanoma patients
Date:8/2/2011

About 50 to 60 percent of patients with melanoma have a mutation in the BRAF gene that drives the growth of their cancer. Most of these patients respond well to two novel agents being studied in clinical trials that inhibit the gene, with remarkable responses that are, unfortunately, almost always limited in duration.

In a study published today as a Priority Report in the peer-reviewed journal Cancer Research, scientists at UCLA's Jonsson Comprehensive Cancer Center tested a combination of small molecules that may, when used with the BRAF inhibitors, help overcome this drug resistance and extend the lives of those with advanced melanoma.

The team, led by researcher Dr. Roger Lo, focused on testing only small molecules that are already being studied in various phases of clinical trials in the hope of developing a combination treatment that can be studied in patients much more quickly than compounds that aren't yet being tested in humans.

"These molecules we tested are already being studied in patients with other cancers, and some of them have very good toxicity profiles with few side effects," said Lo, a Jonsson Cancer Center researcher and an assistant professor of dermatology and molecular and medical pharmacology. "The idea was to combine some of these with the BRAF inhibitors and come up with something that we don't have to wait years and years to use in patients. We need to find a way to combine these molecules so the cancer cell cannot get around them."

This study builds on the discoveries from a previous study published by Lo last year in the journal Nature. That study found that subsets of melanoma patients with BRAF mutations become resistant to BRAF inhibitors through either a genetic mutation in a gene called NRAS or the overexpression of a cell surface receptor protein.

It had been theorized that BRAF was finding a way around the experimental BRAF inhibitors by developing a secondary mutation in
'/>"/>

Contact: Kim Irwin
kirwin@mednet.ucla.edu
310-206-2805
University of California - Los Angeles Health Sciences
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Adjuvant combo shows potential for universal influenza vaccine
2. Graphene and spintronics combo looks promising
3. UT Southwestern researchers use drug-radiation combo to eradicate lung cancer
4. Triple-combo drug shows promise against antiviral-resistant H1N1, UAB researcher says
5. New discovery brings customized tuberculosis therapies based on genotype closer to reality
6. Therapies to improve biochemical functions hold promise as treatments for autism
7. Can we get there from here? Translating stem cell research into therapies
8. New mouse model may lead to new therapies for degenerative diseases
9. Study finds therapies using induced pluripotent stem cells could encounter immune rejection problems
10. NIH researchers create comprehensive collection of approved drugs to identify new therapies
11. Go figure: Math model may help researchers with stem cell, cancer therapies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2014)... , October 16, 2014 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... leading edge technologies including Wocket™, the Smart Wallet, at ... Conferenece. FiRe is a leading global conference on the ... Hosted by Mark Anderson , founder and publisher ...
(Date:10/15/2014)... the pandemic risk from strains of influenza virus increases ... ourselves to become complacent that the most substantial threats ... , Influenza pandemics arise when a new virus strain ... immunity – spreads in the human population. There have ... the worst of which – the 1918 Spanish Flu ...
(Date:10/15/2014)... The German Gauß-Allianz has admitted Johannes Gutenberg University ... the Rhineland-Palatinate science hub continues to maintain a ... computing. , "The acceptance of Johannes Gutenberg ... Gauß-Allianz is a milestone in the national and ... support. The state of Rhineland-Palatinate can be proud ...
Breaking Biology News(10 mins):NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3
... neurodegenerative diseases, such as mad cow disease or its ... infectious protein called a prion. Remarkably, in recent years ... roles in biology, and prions even may act as ... But although prions have received a great deal of ...
... responsible for genital warts was on target at the halfway ... Frazer and trial manager, sexual health specialist Dr David Jardine ... have taken part in the trial so far run from ... has so far proven safe, and we want to know ...
... Bae, Ph.D., Postdoctoral Research Associate in the Baumann ... the way cells protect chromosome ends from misguided ... Molecular Cell, their paper entitled "A RAP1/TRF2 Complex ... Ends" employed a biochemical assay for double-strand break ...
Cached Biology News:Scientists identify prion's infectious secret 2Scientists identify prion's infectious secret 3Baumann Lab defines proteins that distinguish chromosome ends from DNA double-strand breaks 2
(Date:10/22/2014)... DUBLIN , Oct. 22, 2014 ... "Organic Electronics Market by Material, by Application, Geography ... report to their offering. Organic electronics, ... a branch of material science which deals with small ... as organic because small molecules and polymers are carbon ...
(Date:10/20/2014)... 2014 The report “Pharmacy Automation ... Packaging and Labeling Systems, Table-top Counters) by End-user ... Forecasts & Trends to 2019” analyzes and studies ... North America, Europe, Asia-Pacific, and the Rest of ... and 30 figures spread through 300 pages and ...
(Date:10/20/2014)... Texas (PRWEB) October 20, 2014 ... announced that a team from Iowa State University won ... design contest. Using a Convey HC-2ex, the team’s solution ... 14 times faster than the second place finisher. , ... world embarked upon the month long challenge, using a ...
(Date:10/20/2014)... 2014 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") ... orders to $5.8 million and provides a good start to Q4.  ... North America and one in the Middle ... at record levels," said Peter Bruijns , President & CEO. ... of Q3 than they have been for any complete year since ...
Breaking Biology Technology:Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3
... BioMed Realty Trust, Inc.,(NYSE: BMR ) ... underwriter,exercised its over-allotment option in full to purchase ... with BioMed,s previously,announced offering that priced on October ... of common stock, raising net proceeds of,approximately $212.4 ...
... a new dietary supplement resulting from years of, study by ... ... Del-Immune V, BOULDER, Colo., Oct. 6 On Thursday, October ... V(R) induction and its impact on cytotoxicity of,natural killer cells" will be ...
... European authority on natural/ organic certification -, ... /PRNewswire-FirstCall/ - Botaneco Specialty Ingredients,Inc. (Botaneco), a subsidiary ... second generation oleosome product, Hydresia(TM) G2, has,been authorized ... with,the standards for ecological and organic cosmetics. ECOCERT(R) ...
Cached Biology Technology:BioMed Realty Trust Announces Exercise of Over-Allotment Option 2BioMed Realty Trust Announces Exercise of Over-Allotment Option 3EUPROBIO 2008 Presentation to Highlight Latest Immune Research 2Botaneco receives natural ingredient approval from ECOCERT(R) for Hydresia(TM) G2 2Botaneco receives natural ingredient approval from ECOCERT(R) for Hydresia(TM) G2 3
... Phosphate Assay Kit is based on quantification ... Green, molybdate and free orthophosphate. The rapid ... conveniently measured on a spectrophotometer (600-660 nm) ... colorimetric assay kits have been optimized to ...
... The carbohydrate analysis standard is ... and a sugar alcohol; molecular weights ... standard is provided for use with ... carbohydrate analysis kit for column testing ...
Metamine is an autonomous data mining tool that extends the capabilities of conventional research teams. It is a proactive agent that searches for significant results buried within the GeNet data rep...
... CAST Equine EIA Principle: ... LTD4 and LTE4 are products ... 5-lipoxygenase and glutathione-S-transferase. In the ... "Slow Reacting Substances of Anaphylaxis ...
Biology Products: